Skip to Content
Print Share

Medications for Cardiovascular Risk Reduction

About Cardiovascular Risk Reduction:  Cardiovascular disease, or heart disease, is a class of diseases that involve the heart and or its blood vessels. Causes are many with the most common being athersclerosis and hypertension. Cardiovascular disease is the leading cause of death world wide. While it mainly affects older adults early prevention by making lifestyle changes such as diet, exercise and medication have have shown to reduce the risk of complications.

Drugs Used to Treat Cardiovascular Risk Reduction

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
simvastatin X N 4 reviews
4.0

Generic name: simvastatin systemic

Brand names:  Zocor, FloLipid

Drug class: statins

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Zocor X N Add review
0.0

Generic name: simvastatin systemic

Drug class: statins

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Micardis D N X Add review
6.0

Generic name: telmisartan systemic

Drug class: angiotensin receptor blockers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

ramipril D N 3 reviews
7.5

Generic name: ramipril systemic

Brand name:  Altace

Drug class: Angiotensin Converting Enzyme Inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

telmisartan D N X Add review
6.0

Generic name: telmisartan systemic

Brand name:  Micardis

Drug class: angiotensin receptor blockers

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

empagliflozin C N X Add review
0.0

Generic name: empagliflozin systemic

Brand name:  Jardiance

Drug class: SGLT-2 inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

liraglutide C N X Add review
0.0

Generic name: liraglutide systemic

Brand name:  Victoza

Drug class: incretin mimetics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

alirocumab N 9 reviews
5.3

Generic name: alirocumab systemic

Brand name:  Praluent

Drug class: PCSK9 inhibitors

For consumers: dosage,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Jardiance C N X Add review
0.0

Generic name: empagliflozin systemic

Drug class: SGLT-2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

FloLipid X N Add review
0.0

Generic name: simvastatin systemic

Drug class: statins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Altace D N Add review
0.0

Generic name: ramipril systemic

Drug class: Angiotensin Converting Enzyme Inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Repatha N 23 reviews
4.1

Generic name: evolocumab systemic

Drug class: PCSK9 inhibitors

For consumers: dosage, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Victoza C N X Add review
0.0

Generic name: liraglutide systemic

Drug class: incretin mimetics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Praluent N 9 reviews
5.3

Generic name: alirocumab systemic

Drug class: PCSK9 inhibitors

For consumers: dosage, side effects

For professionals: AHFS DI Monograph, Prescribing Information

canagliflozin / metformin C N X Add review
0.0

Generic name: canagliflozin / metformin systemic

Brand names:  Invokamet, Invokamet XR

Drug class: antidiabetic combinations

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts

evolocumab N 23 reviews
4.1

Generic name: evolocumab systemic

Brand name:  Repatha

Drug class: PCSK9 inhibitors

For consumers: dosage,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Invokana C N X Add review
0.0

Generic name: canagliflozin systemic

Drug class: SGLT-2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

canagliflozin C N X Add review
0.0

Generic name: canagliflozin systemic

Brand name:  Invokana

Drug class: SGLT-2 inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Invokamet C N X Add review
0.0

Generic name: canagliflozin / metformin systemic

Drug class: antidiabetic combinations

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Invokamet XR C N X Add review
0.0

Generic name: canagliflozin / metformin systemic

Drug class: antidiabetic combinations

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Legend

Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Off Label This medication may not be approved by the FDA for the treatment of this condition.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Treatment Options

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drugs.com Mobile Apps

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Explore Apps
Hide